Table 3.
Year | Total n (%) | TB (B20.0) n (%) | PCP (B20.6) n (%) |
---|---|---|---|
1996 | 0 | 0 | 0 |
1997 | 108 (10.0) | 3 (3.2) | 3 (6.3) |
1998 | 155 (28.3) | 20 (27.4) | 5 (10.4) |
1999 | 255 (42.5) | 17 (28.8) | 14 (35.9) |
2000 | 316 (44.9) | 31 (42.5) | 5 (17.2) |
2001 | 351 (54.6) | 33 (49.3) | 8 (33.3) |
2002 | 389 (50.5) | 23 (31.5) | 12 (35.3) |
2003 | 392 (50.3) | 33 (47.1) | 12 (37.5) |
2004 | 391 (49.1) | 23 (37.7) | 12 (42.9) |
2005 | 331 (48.8) | 27 (58.7) | 10 (25.0) |
Source: Rio de Janeiro antiretroviral drug database.
HAART = highly-active antiretroviral treatment; TB = tuberculosis; PCP = Pneumocystis carinii pneumonia.